EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Organoid‐based precision medicine in pancreatic cancer

Alica K Beutel iD, Menar Ekizce iD, Thomas J Ettrich iD, Thomas Seufferlein iD, Jessica Lindenmayer, Johann Gout iD, Alexander Kleger iD

United European Gastroenterology Journal · 2025-02 · 13 (1) · 21-33

DOI: 10.1002/ueg2.12701 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift United European Gastroenterology Journal, online erschienen am 14.11.2024. Verfasst von Alica K Beutel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Organoids, Precision Medicine, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, Medizinische Fakultät, Universität Ulm.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) ranks among the leading causes of cancer‐related deaths worldwide. Despite advances in precision oncology in other malignancies, treatment of PDAC still largely relies on conventional chemotherapy. Given the dismal prognosis and heterogeneity in PDAC, there is an urgent need for personalized therapeutic strategies to improve treatment response. Organoids, generated from patients' tumor tissue, have emerged as a powerful tool in cancer research. These three‐dimensional models faithfully recapitulate the morphological and genetic features of the parental tumor and retain patient‐specific heterogeneity. This review summarizes existing precision oncology approaches in PDAC, explores current applications and limitations of organoid cultures in personalized medicine, details preclinical studies correlating in vitro organoid prediction and patient treatment response, and provides an overview of ongoing organoid‐based clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsPrecision MedicinePancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansAntineoplastic AgentsClinical Trials as TopicAnimals

Stichwörter der Autor:innen

PDACdrug response predictiononcologypancreatic ductal adenocarcinomapatient‐derived organoidspersonalized therapypharmacotypingprecision oncologytreatment response

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
  • Institute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, Ulm, Germany.
  • Core Facility Organoids, Medical Faculty of Ulm University, Ulm, Germany.
  • Division of Interdisciplinary Pancreatology, Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.

ORCID-Profile: Alica K Beutel, Menar Ekizce, Thomas J Ettrich, Thomas Seufferlein, Johann Gout, Alexander Kleger

Förderung

  • Deutsche Forschungsgemeinschaft
  • Deutsche Krebshilfe
  • Medizinische Fakultät, Universität Ulm
  • Clinician Scientist Program of Ulm University
  • German Cancer Aid

Zitieren

APA

Beutel, A. K., Ekizce, M., Ettrich, T. J., Seufferlein, T., Lindenmayer, J., Gout, J., & Kleger, A. (2025). Organoid‐based precision medicine in pancreatic cancer. United European Gastroenterology Journal, 13(1), 21-33. https://doi.org/10.1002/ueg2.12701

Vancouver

Beutel AK, Ekizce M, Ettrich TJ, Seufferlein T, Lindenmayer J, Gout J, et al. Organoid‐based precision medicine in pancreatic cancer. United European Gastroenterology Journal. 2025;13(1):21-33. doi:10.1002/ueg2.12701

BibTeX
@article{Beutel2025,
  author = {Beutel, Alica K and Ekizce, Menar and Ettrich, Thomas J and Seufferlein, Thomas and Lindenmayer, Jessica and Gout, Johann and Kleger, Alexander},
  title = {Organoid‐based precision medicine in pancreatic cancer},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  volume = {13},
  number = {1},
  pages = {21--33},
  doi = {10.1002/ueg2.12701}
}
Kostenlos starten →